Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
06/22/2006 | US20060134655 Introducing a polynucleotide expressing a cGMP-visualizing probe into cells, whereby the cGMP-visualizing probe is expressed and made to coexist with cGMP; measuring the change in fluorescence wavelength |
06/22/2006 | US20060134636 Standardization of growth conditions for human embryonic stem cells intended for use in regenerative medicine |
06/22/2006 | US20060134599 Microfluidic device for cell separation and uses thereof |
06/22/2006 | US20060134280 Method for producing retinal neurocyte from neural stem cell derived from iris tissue and retinal, neurocyte produced by the process |
06/22/2006 | US20060134224 Engineered bone marrow |
06/22/2006 | US20060134158 Chitosan/acidic biopolymer hybrid fiber and culture base for animal cells |
06/22/2006 | US20060134138 Recombinant influenza viruses for vaccines and gene therapy |
06/22/2006 | US20060134128 Screening for an inhibitor of binding between human Toll-like receptor 3 and a protein of specific amino acid sequence by contacting a candidate with a transfected cell encoding the protein which expresses the receptor; increased interferon in vivo; antitumor, autoimmune agents; side effect reduction |
06/22/2006 | US20060134125 Purification of antigen-specific T cells |
06/22/2006 | US20060134123 Comprise the gene of interest and a viral capsid or envelope carrying a member of a specific binding pair, the counterpart of which is not directly associated with the surface of the target cell; used in gene therapy |
06/22/2006 | US20060134122 Peptides of syndecan-1 for inhibition of cancer |
06/22/2006 | US20060134098 Immunoglobulin variable region cassette exchange |
06/22/2006 | US20060134093 Fibrin cell supports and methods of use thereof |
06/22/2006 | US20060134084 Therapeutic platelets and methods |
06/22/2006 | US20060134081 Use of marrow-derived glial progenitor cells as gene delivery vehicles into the central nervous system |
06/22/2006 | US20060134079 Implantable medical devices comprising isolated extracellular matrix |
06/22/2006 | US20060134078 Method for culturing neural stem cells using hepatocyte growth factor |
06/22/2006 | US20060134075 Composition and method for improving function of embryonic kidney transplants |
06/22/2006 | US20060134073 Compositions and methods for ex vivo preservation of blood vessels for vascular grafts using analogues of cAMP and cGMP |
06/22/2006 | US20060134069 Erythrocytic cells and method for preserving cells |
06/22/2006 | US20060134067 Loading of cells with antigens by electroporation |
06/22/2006 | DE10342322B4 Verfahren zur Herstellung von endothelialen Progenitorzellen aus apheretisch gewonnenen Monozyten menschlichen oder tierischen Blutes Process for the preparation of endothelial progenitor cells from monocytes obtained apheretisch human or animal blood |
06/22/2006 | DE10111083B4 Chitindeacetylase und Verfahren zu seiner Herstellung Chitin deacetylase and process for its preparation |
06/22/2006 | CA2632836A1 Production from blood of cells of neural lineage |
06/22/2006 | CA2632834A1 Regulating stem cells |
06/22/2006 | CA2591918A1 Cancer-specific spanx-n markers |
06/22/2006 | CA2590943A1 Cell lines for production of replication-defective adenovirus |
06/22/2006 | CA2590693A1 Peptide fractions promoting growth and synthesis of desired product(s) into cell and/or tissue culture |
06/22/2006 | CA2590619A1 Casein kinase 2 antisense therapy |
06/22/2006 | CA2590337A1 Humanized amyloid beta antibodies for use in improving cognition |
06/22/2006 | CA2588180A1 Method of using extracts of epimedium species |
06/22/2006 | CA2587136A1 Methods of using il-21 for adoptive immunotherapy and identification of tumor antigens |
06/21/2006 | EP1672068A1 A method of affinity separation and ligands for use therein |
06/21/2006 | EP1672063A1 Method of introducing nucleic acid |
06/21/2006 | EP1671535A1 Methods for altering levels of phenolic compounds in plant cells |
06/21/2006 | EP1671534A1 Methods for altering levels of phenolic compounds in plant cells |
06/21/2006 | EP1670935A1 Neural colony forming assay |
06/21/2006 | EP1670931A2 Method for the production of fusion proteins in transgenic mammal milk |
06/21/2006 | EP1670925A1 Packaging cells for recombinant adenovirus |
06/21/2006 | EP1670918A1 Leader sequences for use in production of proteins |
06/21/2006 | EP1670902A2 METHOD AND COMPOSITION FOR ENHANCING i IN VITRO /i EMBRYO DEVELOPMENT BY SUPPLEMENTING CULTURE MEDIUM WITH PROSTAGLANDIN OR A PROSTAGLANDIN ANALOG |
06/21/2006 | EP1670901A2 Method of in vitro differentiation of neural stem cells, motor neurons and dopamine neurons from primate embryonic stem cells |
06/21/2006 | EP1670900A2 Enriched pancreatic stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations |
06/21/2006 | EP1670897A2 Igf-1 instructs multipotent adult cns neural stem cells to an oligodendroglial lineage |
06/21/2006 | EP1670829A1 Attachment of cells to surfaces |
06/21/2006 | EP1670825A2 Antibodies to m-csf |
06/21/2006 | EP1670817A2 Uses of spatial configuration to modulate protein function |
06/21/2006 | EP1670509A2 Multiplex vaccines |
06/21/2006 | EP1670493A2 In vitro development of tissues and organs |
06/21/2006 | EP1670415A2 Animal model for protease activity and liver damage |
06/21/2006 | EP1670414A2 Use of cxcr4 protein expression on the surface of stem cells as a marker for tumor tropic potential |
06/21/2006 | EP1670315A2 Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders |
06/21/2006 | EP1670308A1 Chimeric cancer models |
06/21/2006 | EP1670307A2 Coordinated decrease and increase of gene expression of more than one gene using transgenic constructs |
06/21/2006 | EP1629095A4 Compositions and methods for enhanced expression of immunoglobulins from a single vector using a peptide cleavage site |
06/21/2006 | EP1487274A4 Tissue engineering |
06/21/2006 | EP1463797A4 Methods of kidney transplantation utilizing developing nephric tissue |
06/21/2006 | EP1326895B8 Monoclonal antibodies directed against hepatitis b viruses |
06/21/2006 | EP1305041B1 Medicament for the immunotherapy of malignant tumours |
06/21/2006 | EP1297151B1 14911 novel protein kinase molecules and uses therefor |
06/21/2006 | EP1220893B1 Medium for the protein-free and serum-free cultivation of cells |
06/21/2006 | EP1189931B1 Peptide compounds that bind her2 |
06/21/2006 | EP1137790B1 An improved efficiency agrobacterium-mediated plant transformation method |
06/21/2006 | EP1007089B1 Anticoagulant humanised antibodies against factor IX, for use in the treatment of thrombosis |
06/21/2006 | EP0932626B1 G protein-coupled receptor antagonists |
06/21/2006 | EP0723663B1 Hybridoma and anti-kc-4 humanised monoclonal antibody, dna and rna encoding it, kit and diagnostic methods |
06/21/2006 | CN1791875A Method for designing DNA codes used as information carrier |
06/21/2006 | CN1791670A Porcine pancreatic islet cultured with porcine sertoli cells for xenotransplantation |
06/21/2006 | CN1791669A Method and compositions useful for the prediction of blood-brain barrier permeation |
06/21/2006 | CN1791668A Preparation of endodermal stem cells |
06/21/2006 | CN1791331A Collagen biofabric and methods of preparation and use therefor |
06/21/2006 | CN1789418A Amylopectase type starch debranching enzyme gene promoter and its application |
06/21/2006 | CN1789416A Human artificial chromosome containing human antibody lambda light chain |
06/21/2006 | CN1789288A Preparation of carboxymethyl chitosan and its application in tissue surface engineering |
06/21/2006 | CN1260361C Inhibition of Ii synthesis |
06/21/2006 | CN1260360C Lipid kinase |
06/21/2006 | CN1260358C cDNA segment of controlling growth of microspore of paddy, coded result and application |
06/21/2006 | CN1260356C Recombinant gene of soluble part in cytolytic T cell relative antigen 4 and its fusion gene and product |
06/21/2006 | CN1259972C Anticoagulant agent and humanized anti-von willebrand factor monoclonal antibody |
06/20/2006 | USRE39138 antibodies used in enzyme-linked immunosorbent assays for detection of low density lipoproteins, immunoglobulins, collagen, serum and urinary peptides or proteins |
06/20/2006 | US7064256 Hybrid maize 33V62 |
06/20/2006 | US7064255 resistance to diseases and insects, tolerance to heat and drought, reducing the time to crop maturity, greater yield, and better agronomic quality; genetic engineering |
06/20/2006 | US7064254 Cotton cultivar 02X38R |
06/20/2006 | US7064253 Soybean cultivar 4145306 |
06/20/2006 | US7064251 Soybean variety 94B13 |
06/20/2006 | US7064250 Soybean variety 94B74 |
06/20/2006 | US7064249 Plants transformed to express Cry2A δ-endotoxins |
06/20/2006 | US7064248 Method of preparing fertile transgenic corn plants by microprojectile bombardment |
06/20/2006 | US7064244 Transgenic mammals having human Ig loci including plural VH and VK regions and antibodies produced therefrom |
06/20/2006 | US7064196 Genes encoding carotenoid compounds |
06/20/2006 | US7064194 Vectors for animal cells and utilization thereof |
06/20/2006 | US7064190 An isolated complex of a peptide of glutamic acid decarboxylase(with specific 6 contiguous amino acids), and an allele of MHC class II molecules DR3 and DR4; useful for diagnosis and therapy of autoimmune diseases |
06/20/2006 | US7064189 Antibodies that immunospecifically bind to trail receptors |
06/20/2006 | US7064187 Removing a portion of non-human animal's collagen containing material, washing in saline and alcohol; subjecting material to cellular disruption treatment; digesting the material with a proteoglycan-depleting factor and/or glycosidase |
06/20/2006 | US7064186 Comprises chemokine polypeptides for diagnosis, prevention and treatment of cell proliferative, immunological and hematopoietic disorders |
06/20/2006 | US7064185 Antibody for human Cyr61 |
06/20/2006 | US7064111 activating or enhancing T-cell response by locally administering a herpes simplex virus vector with an expressible nucleotide sequence for the soluble costimulatory factor B7-1-Ig or B7-2-Ig, so that the factor is expressed by tumor cells or cells in the immediate area of the tumor |
06/20/2006 | US7063973 HDAC9 polypeptides and polynucleotides and uses thereof |
06/20/2006 | US7063971 Phosphodiesterase enzymes |
06/20/2006 | US7063965 especially that encodes an immunoglobulin constant region such as the Fc portion of human IgG1. |